Common form of heart failure could be treated with already approved anticancer drug

Thanks to new research, a drug capable of reversing a common form of heart failure known as heart failure with preserved ejection fraction (HFpEF) may soon be available. The researchers show that a drug already approved for the treatment of some forms of cancer can reverse HFpEF symptoms and improve the heart's ability to pump blood in an HFpEF animal model.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/01/200129120140.htm